Comparison of dopamine and norepinephrine in the treatment of shock.

Mortality and treatment patterns among patients hospitalized with acute cardiovascular conditions during dates of national cardiology meetings. JAMA Intern Med (2015) 5.38

Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care (2013) 3.40

Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med (2014) 3.37

Septic Shock: Advances in Diagnosis and Treatment. JAMA (2015) 2.37

Recommendations for sepsis management in resource-limited settings. Intensive Care Med (2012) 2.03

Experts' recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care (2015) 1.51

Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation (2010) 1.50

Nontraumatic hypotension and shock in the emergency department and the prehospital setting, prevalence, etiology, and mortality: a systematic review. PLoS One (2015) 1.46

Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock. Crit Care Med (2015) 1.45

Physiological changes after fluid bolus therapy in sepsis: a systematic review of contemporary data. Crit Care (2014) 1.44

Increasing mean arterial blood pressure in sepsis: effects on fluid balance, vasopressor load and renal function. Crit Care (2013) 1.44

Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Crit Care (2016) 1.41

Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care (2010) 1.40

Higher Mean Arterial Pressure Values Correlate with Neurologic Improvement in Patients with Initially Complete Spinal Cord Injuries. World Neurosurg (2016) 1.39

Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort. Crit Care (2012) 1.28

Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother (2011) 1.21

Sepsis-induced cardiomyopathy. Curr Cardiol Rev (2011) 1.21

Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology (2011) 1.21

Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care (2010) 1.18

Survival after shock requiring high-dose vasopressor therapy. Chest (2013) 1.15

Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells. Proc Natl Acad Sci U S A (2011) 1.14

Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.11

Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence (2013) 1.10

Vasopressor dosing in septic shock. Crit Care Med (2013) 1.09

Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care (2011) 1.06

Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int (2012) 1.06

Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care (2014) 1.05

Surviving sepsis: going beyond the guidelines. Ann Intensive Care (2011) 1.02

Pharmacologic agents for acute hemodynamic instability: Recent advances in the management of perioperative shock- A systematic review. Ann Card Anaesth (2015) 1.01

Presence of preexisting antibodies mediates survival in sepsis. Shock (2012) 1.01

The Japanese guidelines for the management of sepsis. J Intensive Care (2014) 0.99

Timing of norepinephrine in septic patients: NOT too little too late. Crit Care (2014) 0.98

Clinical review: Circulatory shock--an update: a tribute to Professor Max Harry Weil. Crit Care (2012) 0.97

The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients. Intensive Care Med (2010) 0.95

The impact of nationwide education program on clinical practice in sepsis care and mortality of severe sepsis: a population-based study in Taiwan. PLoS One (2013) 0.95

Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care. Crit Care (2015) 0.95

Initial emergency department diagnosis and management of adult patients with severe sepsis and septic shock. Scand J Trauma Resusc Emerg Med (2012) 0.94

Severe sepsis and septic shock: management and performance improvement. Virulence (2013) 0.94

Use of inotropes and vasopressor agents in critically ill patients. Br J Pharmacol (2012) 0.93

Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials. Crit Care (2011) 0.93

Intensive care unit-acquired weakness: implications for physical therapist management. Phys Ther (2012) 0.93

Pericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammation. PLoS One (2012) 0.92

Interrogating a clinical database to study treatment of hypotension in the critically ill. BMJ Open (2012) 0.92

Control groups in recent septic shock trials: a systematic review. Intensive Care Med (2016) 0.92

Hospital patterns of use of positive inotropic agents in patients with heart failure. J Am Coll Cardiol (2012) 0.90

The Physiologically Difficult Airway. West J Emerg Med (2015) 0.88

Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis. PLoS One (2015) 0.88

Clinical trials comparing norepinephrine with vasopressin in patients with septic shock: a meta-analysis. Mil Med Res (2014) 0.87

Personalizing blood pressure management in septic shock. Ann Intensive Care (2015) 0.86

Red blood cell transfusion in septic shock - clinical characteristics and outcome of unselected patients in a prospective, multicentre cohort. Scand J Trauma Resusc Emerg Med (2014) 0.86

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy. Nat Rev Cardiol (2011) 0.86

Reduction in insulin sensitivity following administration of the clinically used low-dose pressor, norepinephrine. Diabetes Metab Res Rev (2011) 0.85

Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Pediatrics (2010) 0.85

Prognosis of patients with shock receiving vasopressors. World J Emerg Med (2013) 0.85

Sepsis and septic shock. Nat Rev Dis Prim (2016) 0.85

Pediatric acute kidney injury: A syndrome under paradigm shift. Indian J Crit Care Med (2014) 0.84

New medical therapies for heart failure. Nat Rev Cardiol (2015) 0.83

Thirty years of critical care medicine. Crit Care (2010) 0.83

Sepsis and pregnancy: do we know how to treat this situation? Rev Bras Ter Intensiva (2014) 0.83

Therapeutic strategies for high-dose vasopressor-dependent shock. Crit Care Res Pract (2013) 0.82

Early management of sepsis. Clin Exp Emerg Med (2014) 0.82

Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study. BMC Pharmacol Toxicol (2016) 0.82

Optimal perioperative management of arterial blood pressure. Integr Blood Press Control (2014) 0.82

Drug utilization pattern in critical care unit in a tertiary care teaching hospital in India. Int J Crit Illn Inj Sci (2013) 0.82

[Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy]. Anaesthesist (2017) 0.82

Dopaminergic Regulation of Innate Immunity: a Review. J Neuroimmune Pharmacol (2017) 0.81

Renal macro- and microcirculation autoregulatory capacity during early sepsis and norepinephrine infusion in rats. Crit Care (2013) 0.81

Inotropes and vasopressors: more than haemodynamics! Br J Pharmacol (2012) 0.81

Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials. J Zhejiang Univ Sci B (2013) 0.81

Dynamic arterial elastance predicts mean arterial pressure decrease associated with decreasing norepinephrine dosage in septic shock. Crit Care (2015) 0.81

The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis. PLoS One (2013) 0.80

A case of combined septic and obstructive shock: usefulness of bedside integrated cardiothoracic emergency ultrasonography. Case Rep Emerg Med (2013) 0.80

Mechanical circulatory support in acute cardiogenic shock. F1000Prime Rep (2014) 0.80

Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials. PLoS One (2015) 0.79

Comparison between propofol and dexmedetomidine in postoperative sedation after extensive cervical spine surgery. J Anesth (2011) 0.79

Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure. Acta Anaesthesiol Scand (2016) 0.78

Vasopressors and inotropes in the treatment of human septic shock: effect on innate immunity? Inflammation (2012) 0.78

The interface between monitoring and physiology at the bedside. Crit Care Clin (2015) 0.78

Management of children with sepsis and septic shock: a survey among pediatric intensivists of the Réseau Mère-Enfant de la Francophonie. Ann Intensive Care (2013) 0.78

Pathophysiology, diagnosis, and treatment of infarction-related cardiogenic shock. Herz (2011) 0.78

A systems biology approach to identify intelligence quotient score-related genomic regions, and pathways relevant to potential therapeutic treatments. Sci Rep (2014) 0.78

Vasopressors in septic shock: a systematic review and network meta-analysis. Ther Clin Risk Manag (2015) 0.78

Section 3: Prevention and Treatment of AKI. Kidney Int Suppl (2011) (2012) 0.78

Echocardiography as a guide for fluid management. Crit Care (2016) 0.78

Automatic versus manual changeovers of norepinephrine infusion pumps in critically ill adults: a prospective controlled study. Ann Intensive Care (2015) 0.78

Outcome of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care (2017) 0.78

Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation. Crit Care (2016) 0.77

Blood transfusion practices in sepsis. Indian J Anaesth (2014) 0.77

Comparative study of dopamine and norepinephrine in the management of septic shock. Saudi J Anaesth (2011) 0.77

Right internal jugular vein distensibility appears to be a surrogate marker for inferior vena cava vein distensibility for evaluating fluid responsiveness. Rev Bras Ter Intensiva (2015) 0.77

Clinical examination for diagnosing circulatory shock. Curr Opin Crit Care (2017) 0.76

Norepinephrine: more of a neurohormone than a vasopressor. Crit Care (2010) 0.76

Challenges with Diagnosing and Managing Sepsis in Older Adults. Expert Rev Anti Infect Ther (2016) 0.76

Sepsis: a review for the neurohospitalist. Neurohospitalist (2012) 0.76

ShockOmics: multiscale approach to the identification of molecular biomarkers in acute heart failure induced by shock. Scand J Trauma Resusc Emerg Med (2016) 0.76

Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units. Chin Med J (Engl) (2015) 0.76

Pharmacological management of cardiorenal syndromes. Int J Nephrol (2011) 0.76

Clinical year in review 2014: critical care medicine. Tuberc Respir Dis (Seoul) (2014) 0.76

Does the Mean Arterial Pressure Influence Mortality Rate in Patients with Acute Hypoxemic Respiratory Failure under Mechanical Ventilation? Tuberc Respir Dis (Seoul) (2015) 0.75

Comparison of dopamine and norepinephrine in shock. N Engl J Med (2010) 0.75

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39

Mortality after surgery in Europe: a 7 day cohort study. Lancet (2012) 9.96

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33

Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med (2004) 5.90

Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med (2002) 5.84

Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA (2010) 5.80

Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology (2015) 5.52

Circulatory shock. N Engl J Med (2013) 4.95

Sepsis biomarkers: a review. Crit Care (2010) 4.76

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med (2004) 4.56

Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis (2012) 4.07

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med (2003) 4.04

Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med (2005) 3.97

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90

Pulse pressure variations to predict fluid responsiveness: influence of tidal volume. Intensive Care Med (2005) 3.81

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78

Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care (2013) 3.65

High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest (2005) 3.58

The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med (2006) 3.53

Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med (2011) 3.34

Fluid challenges in intensive care: the FENICE study: A global inception cohort study. Intensive Care Med (2015) 3.27

The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med (2012) 3.18

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med (2003) 3.18

The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med (2014) 3.17

Management of bleeding following major trauma: an updated European guideline. Crit Care (2010) 3.09

Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med (2007) 3.06

C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest (2003) 2.95

Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest (2008) 2.90

Let us use the pulmonary artery catheter correctly and only when we need it. Crit Care Med (2005) 2.83

Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma (2010) 2.82

Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med (2006) 2.74

Do all nonsurvivors of cardiogenic shock die with a low cardiac index? Chest (2003) 2.73

Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med (2005) 2.73

Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med (2013) 2.72

A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med (2013) 2.68

Evaluation of sublingual and gut mucosal microcirculation in sepsis: a quantitative analysis. Crit Care Med (2009) 2.68

Abandon the mouse research ship? Not just yet! Shock (2014) 2.60

Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology (2003) 2.56

Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsis. Crit Care Med (2004) 2.48

Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med (2006) 2.47

Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med (2006) 2.40

Ethics and end-of-life care for adults in the intensive care unit. Lancet (2010) 2.40

Management of bleeding following major trauma: a European guideline. Crit Care (2007) 2.40

Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often? Crit Care Med (2012) 2.39

Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med (2004) 2.33

Severe sepsis in cirrhosis. Hepatology (2009) 2.33

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med (2010) 2.31

Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med (2008) 2.27

The prognostic value of muscle StO2 in septic patients. Intensive Care Med (2007) 2.25

Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med (2003) 2.23

Gamma-globulin levels in patients with community-acquired septic shock. Shock (2009) 2.21

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17

A large-bolus injection, but not continuous infusion of sodium selenite improves outcome in peritonitis. Shock (2009) 2.17

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care (2010) 2.11

Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med (2010) 2.11

Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: myth or reality? Transfusion (2009) 2.11

Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Crit Care Med (2011) 2.10

Randomized, controlled clinical trials in sepsis: has methodological quality improved over time? Crit Care Med (2002) 2.10

The Surviving Sepsis Campaign: raising awareness to reduce mortality. Crit Care (2003) 2.07

Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med (2012) 2.06

Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med (2010) 2.05

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. Intensive Care Med (2003) 2.05

Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med (2003) 2.01

An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP) study. Intensive Care Med (2006) 2.00

Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med (2008) 2.00

Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit Care Med (2003) 1.98

Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care (2009) 1.97

Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care (2011) 1.91

Monitoring the microcirculation in the critically ill patient: current methods and future approaches. Intensive Care Med (2010) 1.88

Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J (2004) 1.86

The impact of hospital and ICU organizational factors on outcome in critically ill patients: results from the Extended Prevalence of Infection in Intensive Care study. Crit Care Med (2015) 1.85

Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents (2011) 1.80

Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med (2005) 1.77

Arterial pressure-based cardiac output monitoring: a multicenter validation of the third-generation software in septic patients. Intensive Care Med (2010) 1.77

Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit Care Med (2014) 1.77

Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Crit Care (2012) 1.76

Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests. Crit Care Med (2005) 1.72

Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med (2004) 1.72

Ventriculostomy-related infections in critically ill patients: a 6-year experience. J Neurosurg (2005) 1.71

The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction. Intensive Care Med (2002) 1.71

Characteristics and outcomes of cancer patients in European ICUs. Crit Care (2009) 1.70

Does a higher positive end expiratory pressure decrease mortality in acute respiratory distress syndrome? A systematic review and meta-analysis. Anesthesiology (2009) 1.68

Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care (2013) 1.66

Post mortem examination in the intensive care unit: still useful? Intensive Care Med (2004) 1.66

Sublingual and muscular microcirculatory alterations after cardiac arrest: a pilot study. Resuscitation (2011) 1.63

Impaired subcortical and cortical sensory evoked potential pathways in septic patients. Crit Care Med (2002) 1.63

Beneficial effects of recombinant human activated protein C in a ewe model of septic shock. Crit Care Med (2007) 1.61

Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med (2009) 1.61

Sepsis is associated with altered cerebral microcirculation and tissue hypoxia in experimental peritonitis. Crit Care Med (2014) 1.60

Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury. Crit Care (2010) 1.59

β-lactam antibiotic concentrations during continuous renal replacement therapy. Crit Care (2014) 1.59

Early alterations of red blood cell rheology in critically ill patients. Crit Care Med (2009) 1.58

Septic shock of early or late onset: does it matter? Chest (2004) 1.58